A new AI capability that delivers analysis-ready Media Intelligence. More than just a product launch, this is a shift in how communications teams monitor, understand and act on media coverage.
Two people were the first to receive the therapy for a condition that damages the spinal cord and optic nerve A man and a woman with a rare and devastating autoimmune disease have been in remission for more than 15 years after receiving a stem-cell transplant. The positive results, which were reported in Med , suggest that the experimental treatment warrants a larger clinical trial, say scientists.
Credit: Steve Gschmeissner/Science Photo Library A man and a woman with a rare and devastating autoimmune disease have been in remission for more than 15 years after receiving a stem-cell transplant1. The positive results, which were reported in Med, suggest that the experimental treatment warrants a larger clinical trial, say scientists.